Introduction
A distinguishing feature of eukaryotic cells is the presence of membranebound organelles within the cytoplasm. These organelles have distinct functions that are reflected by the presence of specific proteins within their membrane(s), and a unique luminal composition. Newly made proteins are targeted from their site of synthesis, the cytosol, to the appropriate organelle by virtue of specific signal sequences. These act as intracellular 'address labels' and ensure that a precursor protein is delivered to the correct location. These signal sequences usually take the form of amino acid motifs within the precursor protein, and distinct signals for targeting proteins to the nucleus, mitochondrion, peroxisome and endoplasmic reticulum (ER) have been identified. The ER plays a key role within the cell since it is the entry point into the 'secretory pathway', providing access to all of the compartments of that pathway and the cell surface. This chapter will focus on protein targeting and translocation at the ER of mammalian cells, drawing on studies of other organisms where these are better understood. When a live mammalian cell is viewed under a microscope, one sees that the ER is closely associated with the nucleus and forms a reticular network that stretches to the periphery of the cell (see Figure 1 ).
ER signal sequences
For proteins destined to enter the ER, the signal sequence, or targeting motif, is particularly well characterized and defined as a continuous stretch of 6-20 hydrophobic amino acid residues usually located towards the N-terminus of the protein, and often flanked by one or more basic residues [1] . ER signal sequences may either be cleaved following protein targeting, or remain an integral part of the mature protein. Cleavable signal sequences are removed during translocation across the ER membrane by the action of the signal peptidase complex located on the luminal side of the membrane. Many secretory proteins have cleavable signal sequences ( Figure 2 ).
Not all proteins possessing cleavable signal sequences are destined for the ER lumen, and many are integrated into the ER membrane. The membrane integration of such proteins is achieved by the presence of a second stretch of hydrophobic amino acids, C-terminal to the cleavable signal sequence. This region is called a 'stop-transfer' sequence since it acts to stop the translocation, or transfer, of the protein across the membrane, and functions as the transmembrane domain of the mature protein ( Figure 2 ). Many other integral mem-brane proteins contain uncleaved signal sequences (Figure 2 ). In this case, a single 'signal-anchor' sequence serves two functions, i.e. targeting the protein to the ER and acting as the transmembrane anchor [1] .
A special class of integral membrane protein has an uncleaved signal sequence located near the extreme C-terminus of the polypeptide (Figure 2 ). These have been denoted 'tail-anchored' proteins and their biosynthesis is quite distinct from all the other ER-targeted proteins described here [2] . In particular, these proteins are inserted post-translationally via a novel mechanism that is poorly characterized and which falls outside the scope of this review.
Figure 2. ER targeting signals and their resulting transmembrane topologies
Hydrophobic ER signal sequences are depicted by a coiled motif. (a) S denotes a cleavable signal sequence, SA a signal-anchor sequence, ST a stop-transfer sequence and TA a tail-anchor sequence. Charged regions flanking these hydrophobic sequences can influence the final orientation of transmembrane proteins [1] and are represented by a plus sign. (b) A type-I membrane protein retains its C-terminus in the cytosol while a type-II membrane protein retains its N-terminus in the cytosol [1] . Where appropriate, the cleavage of a signal sequence by signal peptidase (SPase) is indicated by an arrow. 
Signal recognition particle
The synthesis of proteins destined for the ER begins on cytosolic ribosomes. As the ER signal sequence is usually located towards the N-terminus of the protein, the signal exits the ribosome at an early stage of synthesis. This exposed signal sequence is now available for 'sampling' by the cytosolic signalrecognition particle (SRP; Figure 3 ) [3] . Mammalian SRP is a ribonucleoprotein complex comprising six different polypeptides assembled on a 7 S RNA molecule [4] . The most important protein subunit of SRP is the 54 kDa polypeptide (SRP54), and it is this subunit that recognizes and binds to the hydrophobic ER targeting signals. The structure of the SRP54 subunit is crucial to its role, and three domains have been identified on the basis of several criteria [4] . These are the N-terminal N domain, the central G domain, which can bind and hydrolyse GTP, and the C-terminal methionine-rich M domain that binds to both the hydrophobic ER targeting signals and the 7 S RNA component [4] . The binding of the ER signal sequence by SRP54 allows other subunits of the SRP to mediate a slowing down in the rate of protein synthesis [4] . This reduction in translation rate by the SRP prevents large amounts of the new protein becoming exposed to the cytosol and perhaps developing a tightly folded tertiary structure that would interfere with the subsequent translocation of the nascent polypeptide across the ER membrane.
Homologues of SRP54 have been identified in a wide range of organisms including mycoplasma, bacteria and yeast, and in each case the homologue is 4 Essays in Biochemistry volume 36 2000 [5] . The most prominent feature of the T. aquaticus SRP54 homologue M domain is a deep grove lined by the side chains of hydrophobic amino acids: this is almost certainly the signal-sequence-binding pocket of the M domain [6] .
SRP-dependent targeting to the ER membrane
Once the SRP has bound to the ER targeting signal present on a short, incomplete, polypeptide chain emerging from the ribosome, this ribosome-nascent chain-SRP complex is specifically targeted to the ER membrane by virtue of an interaction between SRP and the SRP receptor ( Figure 3 ). The binding of the SRP to a ribosome-nascent-chain complex, followed by the specific interaction of this complex with the SRP receptor, provides an efficient targeting mechanism for the presentation of nascent polypeptides at the ER translocation site ( Figure 3 ). It appears that this SRPdependent targeting route is not inhibited by the binding of non-translating ribosomes to the ER translocation site [7, 8] , although there is by no means agreement on this point [9] .
The SRP receptor is a heterotrimer that is restricted to the ER membrane by virtue of its ␤ subunit, which has a transmembrane domain. The ␣ subunit of the SRP receptor associates peripherally with the cytosolic face of the ER membrane via its tight interaction with the SRP receptor's ␤ subunit [4] . In fact, the transmembrane domain of the ␤ subunit can be deleted without a loss of function. This suggests that the SRP receptor need only be transiently associated with the ER membrane in order to carry out its function; presumably this can take place via interactions with components other than the SRP receptor ␤ subunit [10] . Like the SRP54 subunit, both subunits of the SRP-receptor complex can bind GTP; indeed the primary and tertiary structures of the N and G domains of prokaryotic SRP54 and SRP-receptor ␣-subunit homologues are closely related [11] . The binding of GTP to both the SRP receptor's ␣ subunit [12] and ␤ subunit [11] is necessary for function ( Figure 3) .
Currently, the most widely accepted model of SRP-dependent targeting to the ER membrane is that the GTP-binding site of the SRP54 protein is empty when it binds to an ER targeting signal [4, 12] , albeit that this view is not universal [13] . Upon arrival at the ER membrane, SRP54 will interact with the SRP-receptor ␣ subunit, which also has an empty GTP-binding site at this stage [12] . The proposal that the GTP-binding sites of SRP54 and the SRPreceptor ␣ subunit are both empty at the start of the 'SRP cycle' (Figure 3) is strongly supported by the crystal structures of their prokaryotic homologues. The G domains of both proteins appear to have a stable tertiary structure even in the absence of any bound nucleotide [5, 11] . Following the interaction of SRP54 with the SRP-receptor ␣ subunit, the co-operative binding of GTP to both of these proteins stabilizes the SRP-SRP-receptor complex and initiates the transfer of the nascent chain's signal sequence from SRP54 to the proteins of the ER translocation site [12] . The subsequent hydrolysis of GTP by both SRP54 and the SRP-receptor ␣ subunit leads to the dissociation of the complex and regenerates both components for new rounds of ER targeting (Figure 3) . Thus the components of the SRP-dependent targeting cycle use GTP binding and hydrolysis to (i) regulate the delivery of nascent precursor proteins to the ER membrane, (ii) optimize their presentation to the ER translocation complex and (iii) recycle the targeting components.
SRP-independent ER targeting
It is clear that some proteins with apparently 'classical' N-terminal ER targeting signals can be targeted to the ER membrane independently of SRP binding. In higher eukaryotes such proteins are generally short secretory proteins of around 70 amino acids where the synthesis of the protein is completed just as the signal sequence is emerging from the ribosome and therefore available for SRP binding. In eukaryotes SRP seems to function solely in mediating the targeting of nascent, ribosome-bound, polypeptides and cannot therefore assist the targeting of these short proteins [14] . SRPindependent targeting to the ER membrane requires ATP and cytosolic chaperones including members of the Hsp70 family [15] .
The SRP-independent pathway seems to be used extensively in the yeast Saccharomyces cerevisiae, where the genetic elimination of the SRP-dependent targeting route does not completely prevent the targeting of proteins to the ER membrane. Yeast can survive without a functional SRP or SRP receptor, suggesting that there is at least one other pathway that allows proteins to be directed to the ER. Whereas yeast can survive in the absence of SRP-dependent protein targeting, the growth of the cells is severely diminished. Nevertheless, one must conclude that alternative targeting routes can deliver enough protein to the ER to enable cell survival. Studies in vivo in yeast indicate that subtle features of the ER targeting signal define which targeting route a particular precursor uses for delivery to the ER membrane [16] .
Membrane insertion
After SRP-bound ribosome nascent chains are released from the SRP, the nascent chain interacts with the ER translocation machinery. During insertion into the ER, the nascent chain has two possible destinations: it can be completely translocated across the ER membrane and enter the lumen as a secretory protein; alternatively, only part of the protein may be translocated across the membrane leaving other regions exposed to the cytosol. In the latter case the protein is left spanning the ER membrane. Essentially all membrane proteins with a cleavable ER signal sequence assume a type-I orientation in the membrane, where the N-terminus of the protein is translocated into the ER lumen while the C-terminus remains in the cytosol (Figure 2) .
The final topology of membrane proteins with an uncleaved, signalanchor, sequence is generally governed by the 'positive inside' rule. This states that basic residues adjacent to a signal-anchor domain will remain on the cytosolic side of the ER membrane (see [1] and Figure 2) . Hence, net positive charge N-terminal of a transmembrane domain results in the C-terminus being translocated (type-II orientation, see Figure 2 ), whereas net positive charge Cterminal of a transmembrane domain results in the N-terminus being translocated (type-I orientation, see Figure 2 ). In fact, other factors such as the length and hydrophobicity of the transmembrane domain and the presence of extensive secondary structure can also influence the final transmembrane orientation of a membrane protein with a signal-anchor sequence [17] . Regardless of transmembrane orientation, or the number of times a protein spans the membrane, all membrane proteins except those with a tail anchor (see above) appear to be integrated by the classical ER translocation complex [1, 18] .
The translocation site of the ER membrane
A number of studies using assays in vitro and yeast genetics have been carried out by several laboratories and have led to the identification of the components of the ER translocation site [3, [18] [19] [20] . It is worth emphasizing that this ER translocation site or 'translocon' is responsible for both the translocation of secretory proteins and the integration of membrane proteins, dependent only upon the specific signal sequences a particular precursor protein possesses.
The structure of the ER translocon has been established at low resolution. These studies show that the Sec61 complex (see below) forms an oligomeric ring structure in the ER membrane with a central pore of at least 20 Å ( [21] and references therein). This oligomer constitutes an aqueous pore that spans the entire ER membrane, and which has an alternative conformation where the pore diameter increases to 60 Å [21] . Furthermore, the central pore of the ER translocon appears to align precisely with the site where a newly synthesized polypeptide emerges from the ribosome [22] . The first evidence that protein translocation across the ER membrane took place via a water-filled pore came from electrophysiological studies carried out in the laboratory of the Nobel laureate Günter Blobel [23] . The subsequent structural studies also included a contribution from Blobel and colleagues [22] and allowed us to actually see the aqueous pore [21] .
Components of the translocation site
The water-filled protein-lined channel that crosses the ER membrane is formed by oligomers of the Sec61 complex [21] . The mammalian Sec61 complex is a heterotrimer composed of the Sec61␣, Sec61␤ and Sec61␥ subunits and the complex is essential for protein translocation and integration at the ER membrane (Figure 4) [19] . The mammalian Sec61␣ subunit appears to form the major component of the water-filled transmembrane channel through which proteins are transported across and integrated into the ER membrane (see Figure 5 and [24] ). The mammalian Sec61␤ subunit has recently been shown to facilitate co-translational translocation at the ER membrane and may also recruit the signal peptidase complex into a transient association with the ER translocation site [25] . The exact role of the mammalian Sec61␥ subunit remains to be elucidated although studies of S. cerevisiae indicate that this component has a crucial role in protein translocation [3] . Both Sec61␣ and Sec61␤ extend up into the docked ribosome, and are therefore adjacent to the translocating polypeptide as it passes through a continuous channel that starts inside the ribosome and extends through the ER membrane to its luminal face [3, 19, 22] .
Despite the aqueous nature of the ER translocation channel ( Figure 5 ), when hydrophobic targeting signals enter this channel they appear to have direct lateral access to the phospholipids of the membrane bilayer ( Figure 5 ) [19, 20] . To date, the structure of the ER translocon provides no clue as to how this access to the lipid phase is achieved [21, 22] . Nevertheless, such access would greatly facilitate the transfer of hydrophobic transmembrane regions out of the translocation site and into the bilayer (see Figure 5) .
In addition to the subunits of the Sec61 trimer, a second component, the translocating-chain-associating membrane (TRAM) protein, has been shown to be adjacent to specific regions of nascent polypeptides during their insertion into the ER translocation site [19, 21] . In contrast to the Sec61 complex, the TRAM protein is restricted to higher eukaryotes. Although TRAM is not essential for the membrane translocation and integration of all proteins, it is required by many precursors and stimulates this process for many others [3, 19] . Although the exact function of the TRAM protein has yet to be estab- lished, it is clear that the interaction of the TRAM protein with a nascent precursor is dependent upon the properties of its signal sequence [21] . The most recent suggestion for a function of the TRAM protein is that it can regulate the access of a nascent polypeptide within the ER translocation channel to the cytosol (see Figure 5 and [26] ).
Gating of the ER translocation channel
During the early stages of membrane translocation, the ribosome creates a tight seal with the ER translocon and thereby closes the cytosolic face of the channel and promotes vectorial transport of the nascent chain through the translocon [27] . The luminal end of the ER translocon can also be closed in a regulated manner and this function is carried out by the ER chaperone BiP [28] . BiP can block the luminal end of both active (translocating) and inactive (empty) translocons, it therefore plays a key role in maintaining the permeability barrier of the ER membrane and in preserving the gradients established across it, for example that of Ca 2ϩ [28] . The opening and closing of the seals at the two ends of the ER translocon is tightly regulated in response to signals such as nascent chain length and the presence of a transmembrane region in the ribosome [27, 28] . This system ensures that both ends of the translocon are never open at the same time and hence maintains the various chemical gradients established across the ER membrane. It seems clear that the lateral exit of a hydrophobic transmembrane domain, or cleavable signal sequence, from the ER translocon into the centre of the phospholipid bilayer ( Figure 5 ) must also be controlled or regulated in Figure 5 . Locations where the water-filled ER translocon is 'gated' The cylindrical pore represents an ER translocation site constructed from oligomers of the Sec61 complex. The directions of translocation and integration are indicated by arrows. Locations at which access to and from the water-filled translocon is regulated (gated) are as follows: (i) on the cytoplasmic face of the ER membrane by ribosome binding [27] and the translocating-chain-associating membrane (TRAM) protein [26] ; (ii) on the luminal face of the ER membrane by BiP [28] and (iii) within the plane of the membrane [19, 20, 26] .
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Cytosol ER lumen i some fashion [19, 20] . Whereas it has been suggested that Sec61␤ [19] or the TRAM protein [28] may have some role in this process, exactly how such lateral exit is controlled is far from clear.
Inside out?
The ER is a major site of protein synthesis and it can recognize misfolded proteins and unassembled protein subunits by a process generally known as 'quality control'. It has recently become apparent that these misfolded proteins are returned from the ER to the cytosol where they are degraded by the proteasome-mediated pathway [29] . Clearly this first requires the proteins to be moved in a retrograde fashion out of the ER and into the cytosol. Several studies indicate that the Sec61 complex is at least partly responsible for this retrograde transport or 'dislocation' of misfolded proteins from the ER to the cytosol [29] . Quite how the Sec61 complex can co-ordinate its role in transporting proteins in two directions is unknown. One possibility is that forward translocation occurs at the ER, while retrograde translocation takes place at a distinct spatial location within the cell, namely the ER-Golgi intermediate compartment [30] .
Accessory components at the ER translocation site
While the complexity of the ER translocon should now be apparent, we have so far restricted our description to the key players in the process of translocation. In fact it has long been known that many of the proteins entering the ER undergo alterations and modifications. Furthermore, most of these changes can occur while the protein is being inserted into or translocated across the membrane. This means that the ER components which carry out these changes must be closely associated with the translocon, albeit that they are not required for the actual translocation process [31] and can therefore be viewed as accessory components. Accessory components like the signal peptidase and oligosaccharyltransferase are multisubunit protein complexes that do not co-purify with the core components of the ER translocon [3] (Figure 6 ). It is not clear how all of these components can gain access to newly translocating chains to carry out their modification functions [31] . It also remains to be established whether each ER translocon is associated with a full set of accessory components, or whether a single accessory component can service several active ER translocons, associating transiently with each in turn.
Outlook
The future will bring great refinement to our understanding of protein synthesis at the ER. We can look forward to knowing how GTP-binding proteins co-ordinate the SRP-dependent targeting process. A high-resolution structure of the ER translocon core must surely come and will provide the framework on which to hang the molecular detail of the translocation process. In this respect, a major question that remains unresolved is what provides the actual driving force for the movement of the polypeptide chain through the ER translocon? Trying to understand the regulated opening and closing of the translocon ('gating'), both at its two ends and within the plane of the membrane, will be a major focus of future studies. An even greater challenge will be trying to fathom how the translocation site can accommodate so many accessory protein complexes and understanding how the structure and composition of the translocon alter during the translocation process. 
Summary

. Accessory components of the ER insertion site
In addition to the core components of the ER translocation site, i.e. the Sec61 complex and the TRAM protein, the SRP-receptor complex (SR) and a number of accessory components must be closely associated with the site during translocation. These accessory components include the signal peptidase complex (SPC), the oligosaccharyltransferase complex (OST) and a number of molecular chaperones and folding factors (BiP, calnexin, calreticulin, ERp57 and PDI). 
